CCNO, cyclin O, 10309

N. diseases: 67; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4288305
Disease: Recurrent Glioblastoma
Recurrent Glioblastoma
0.020 Biomarker disease BEFREE The purpose of this study was to evaluate the feasibility of procarbazine and CCNU chemotherapy for recurrent glioblastoma multiforme (GBM) with O<sup>6</sup>-methylguanine-DNA-methyltransferase (MGMT) promoter methylation. 29892208 2018
CUI: C4288305
Disease: Recurrent Glioblastoma
Recurrent Glioblastoma
0.020 Biomarker disease BEFREE Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial. 26762204 2016